ClinicalTrials.gg
RecruitingNCT05722002CARESUpdated Aug 28, 2026

Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial

A Phase 4 interventional study of NSAID and Opioid in Surgery and Pain, Postoperative, sponsored by University of Michigan. Recruiting at 8 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by University of Michigan · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2023; still recruiting 3 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.

Planned enrollment
5th of 229
900 · median 90
Started
2023
with 10 others
Phase 4
84 of 229
12 open now
Primary completion
2027-02
later than 13 of 24 live
Registered
189th of 229
by date

Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 5th largest by planned enrollment, is one of 11 that started in 2023, is one of 84 in phase 4, reaches primary completion later than 13 of the 24 other live ones, and was the 189th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

About Anti-Inflammatory Agents, Non-Steroidal

A class of medicines: which ones, and the studies of each, are on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, or all of them as a file.
02

Study summary

This trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) plus acetaminophen or low dose opioids plus acetaminophen).

It is anticipated that the NSAID group will have superior clinical outcomes and fewer side effects when compared to the opioid group.

03

Conditions studied

  • Surgery
  • Pain, Postoperative

Browse trials for

Keywords

  • Medications after surgery
  • NSAIDS
  • Acetaminophen
  • Opioids
  • laparoscopic gallbladder removal
  • inguinal hernia repair
  • breast lumpectomy
  • Analgesics, non-narcotic
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No significant analgesic medication use before surgery: For this study, significant analgesic medication use before surgery as use of prescriptions for opioid or NSAID medications in the past 30 days, or over-the-counter NSAID use on greater than 7 of 30 past days, as reported by the patient.
  • One of three common low-risk surgical procedures: For this study, the three-common low-risk surgical procedures will include laparoscopic gallbladder removal, inguinal hernia repair, and breast lumpectomy.

Exclusion criteria

Exclusion Criteria:

  • Anticipated other surgery within 6 months or anticipated of less than 6 months
  • Patients with to NSAID drugs in the NSAID arm, opioid drugs in the OPIOID arm, or acetaminophen will be excluded. There are specific contraindications that will be reviewed per protocol.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
900 participants (estimated)

Study arms

  • Other
    NSAID regimen

    Surgical teams will elect for one of the medications within the treatment arm to which the patient is randomized.

    Drug: NSAID · Drug: Acetaminophen

  • Other
    Opioid regimen

    Drug: Opioid · Drug: Acetaminophen

Interventions

  • DrugAnti-Inflammatory Agents, Non-SteroidalStudies of Anti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory Agents, Non-Steroidal pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given: * Ibuprofen 600 milligram (mg) by mouth every six hours as needed for pain (10 doses) * Celecoxib 400 mg by mouth once then 200 mg every twelve hours as needed for pain (10 doses) * Naproxen 500 mg by mouth once then 250 mg by mouth every eight hours as needed for pain (10 doses)

  • DrugOpioidsStudies of OpioidsOpioids pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Once randomized to this group the surgical team will elect for 1 of the following treatment options to be given: * Oxycodone 5 mg by mouth every four to six hours as needed for pain, 10 doses * Morphine 7.5 mg by mouth every four to six hours as needed for pain, 10 doses * Hydromorphone 2 mg by mouth every four to six hours as needed for pain, 10 doses

  • Acetaminophen 1000 mg by mouth every 6 hours around the clock for the first three days after surgery then as needed thereafter (20 doses).

06

What researchers measure

Primary outcomes

  1. Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery

    This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.

    Time frame: 7 days post surgery

  2. Safety outcome - number and severity of any adverse medication-related symptoms over 7 days post surgery

    Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 7 days post surgery.

    Time frame: 7 days post surgery

Secondary outcomes

  1. Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance v1.0 4a questionnaire

    This is a 4 question survey in which participants will rate statements pertaining to quality of sleep. Participants will also rate sleep quality as very poor (5), poor (4), fair (3), good (2), or very good (1).

    Time frame: 1 month post surgery

  2. Clinically important adverse events

    The study team will review charts for unplanned postoperative clinical interactions related to pain (patient messages, phone calls, non-routine clinic visits related to pain) and emergency room visits, hospitalizations, and 30-day complications after discharge measured using the American College of Surgeons' (ACS) National Surgical Quality Improvement Program (NSQIP) definitions.

    Time frame: 180 days post surgery

  3. Patient Global Impression of Change (PGIC)

    The perception of improvement after treatment will be assessed by the patient global impression of change PGIC (range 0-7).

    Time frame: up to 1 month after surgery

  4. Quality of Recovery (QoR) 15

    There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.

    Time frame: 3 days post surgery

  5. Quality of Recovery (QoR) 15

    There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.

    Time frame: 7 days post surgery

  6. PROMIS Pain Interference 4a

    This is a 4 question survey that assesses the degree to which pain interferes with various aspects of life. Items are scored on a 1 ("Not at all") to 5 ("Very much") scale with a range of 4 - 20. Higher scores indicate greater pain interference.

    Time frame: 3 months

  7. PROMIS Preference score 29+2 Profile v2.1

    This is a 31 question survey that includes questions to evaluate each of 7 domains (physical function, anxiety, depression, fatigue, sleep disturbance, social functioning, and pain interference) using a 5- point Likert scale, as well as a single item to assess pain severity on a 0-10 scale as well as 2 questions for cognitive function. Higher scores are indicative of better health.

    Time frame: 3 months

  8. Substance use based on the Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) tool

    This National Institute on Drug Abuse (NIDA) TAPS tool has part 1 (5 questions) and part 2 (possible 9 questions).

    Time frame: 180 days post surgery

  9. National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question

    Time frame: 3 months

  10. National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question

    Time frame: 180 days

  11. New prolonged opioid use

    This will include greater or equal to 1 opioid prescription post-discharge between 4-180 days post discharge.

    Time frame: days 4-180 post surgery

  12. Chronic pain based on Brief Pain Inventory (BPI) pain intensity score at 180 days post surgery

    One question survey in which the participants rate pain intensity recorded (0-10), ten being the worst.

    Time frame: 180 days post surgery

  13. Chronic pain based on Body Map

    Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.

    Time frame: 180 days post surgery

  14. Acute pain based on The Michigan Body Map

    Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.

    Time frame: 7 days post surgery

  15. Healthcare Utilization related to pain at 1 month

    Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to one month later for the following three events: (1) postoperative clinical interactions related to pain in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.

    Time frame: within 1 months after surgery

  16. Healthcare Utilization related to pain at 6 months

    Participants will answer questions about their healthcare utilization related to pain for the time period from date of surgery to six months later related to pain for the following three events: (1) postoperative clinical interactions in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.

    Time frame: within 6 months after surgery

07

Study locations

8 of 8 sites recruiting
08

References and documents

Publications

  • Bicket MC, Ladha KS, Haroutounian S, McFarlin K, Neff M, McDuffie RL, Waljee JF, Wijeysundera DN, Brummet C, Li Y; CARES Investigators. Comparing Analgesic Regimen Effectiveness and Safety after Surgery (CARES): protocol for a pragmatic, international multicentre randomised trial. BMJ Open. 2025 Apr 5;15(4):e099925. doi: 10.1136/bmjopen-2025-099925. PubMed 40187774 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results of the trial that is not subject to restrictions based on data sharing agreements (e.g., prescription drug monitoring program data), after deidentification.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Anticipated summer of 2028 with no end date.

Access criteria: Investigators whose proposed use of the data has been approved by a review committee and the sponsor. The type of analyses will be for analyses related to aims in the proposal. Proposals may be submitted up to 36 months after data availability, after which data will be available in the data warehouse but without investigator support.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2023 (actual). Primary completion is estimated for Feb 2027, 48 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 48 months is above that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2023
First posted
Feb 10, 2023
StartActual
Feb 6, 2023
Primary completionEst.
Feb 10, 2027
CompletionEst.
Aug 31, 2027
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05722002
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Mark Bicket, MD, PhD (Associate Professor, University of Michigan) — Principal investigator
First posted
Feb 10, 2023
Start date
Feb 6, 2023
Primary completion
Feb 10, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Sarah Clark, BA
Contact
sarahmcl@med.umich.edu
734-232-0324
Mark Bicket, MD, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids

Start the discussion